文献速递肾癌与肾肿瘤

临床T1期肾细胞癌病理分期上调至T3a时,部分肾切除术与根治性肾切除术相比复发风险更高

Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3a.
PubMed 文献 · J Urol · 2017-03-06

回顾性分析2006年至2014年1250例临床局限性T1期肾细胞癌行部分或根治性肾切除术的患者,中位随访37个月。全体T1期患者中两种术式无复发生存无差异;140例(11%)病理上调至T3a,其中44例(31.4%)复发,中位随访38个月,部分肾切除术与更短的无复发生存相关(多因素复发HR 5.39,95%CI 1.94-14.9,p=0.001)。

要点

  • 临床T1期肾细胞癌中140例(11%)病理上调至T3a。
  • 上调至T3a者部分肾切除术后无复发生存短于根治性肾切除。
  • 上调至T3a者多因素复发HR 5.39(95%CI 1.94-14.9,p=0.001)。

核心结论

  • 临床T1期肾细胞癌中部分患者病理上调至T3a,这部分患者行部分肾切除术的无复发生存似劣于根治性肾切除术。

研究设计与样本

  • 回顾性队列研究,纳入2006年至2014年因临床局限性T1期肾细胞癌行部分或根治性肾切除术的1250例患者。

主要发现

  • 中位随访37个月,全体患者共观察到86例复发(7%)。
  • 全体临床T1期肾细胞癌中,部分肾切除术与根治性肾切除术的无复发生存无差异。
  • 140例(11%)病理上调至T3a,其中44例(31.4%)复发,中位随访38个月。
  • 上调至T3a者中,部分肾切除术与更短的无复发生存相关:单因素分析复发HR 2.04(95%CI 1.12-3.68,p=0.019),多因素分析复发HR 5.39(95%CI 1.94-14.9,p=0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We studied recurrence-free survival after partial vs radical nephrectomy for clinical stage T1 renal cell carcinoma in all patients and in those up staged to pathological stage T3a. MATERIALS AND METHODS: We retrospectively reviewed the records of 1,250 patients who underwent partial or radical nephrectomy for clinically localized T1 renal cell carcinoma between 2006 and 2014. Recurrence-free survival was estimated using the Kaplan-Meier method and evaluated as a function of nephrectomy type with the log rank test and Cox models, adjusting for clinical, radiological and pathological characteristics. RESULTS: A total of 86 recurrences (7%) were observed during a median followup of 37 months. No difference in recurrence-free survival between partial and radical nephrectomy was found among all clinical stage T1 renal cell carcinomas. T3a up staging was noted in 140 patients (11%) and recurrent disease was observed in 44 (31.4%) during a median followup of 38 months. Among up staged T3a cases partial nephrectomy was associated with shorter recurrence-free survival compared to radical nephrectomy on univariable analysis (recurrence HR 2.04, 95% CI 1.12-3.68, p = 0.019) and multivariable analysis (recurrence HR 5.39, 95% CI 1.94-14.9, p = 0.001). CONCLUSIONS: In a subgroup of patients clinically staged T1 renal cell carcinoma will be pathologically up staged to T3a. Among these patients those who undergo partial nephrectomy appear to have inferior recurrence-free survival relative to those who undergo radical nephrectomy.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Shah PH, Moreira DM, Patel VR, et al. Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3a. J Urol. 2017. PMID: 28274620. doi:10.1016/j.juro.2017.03.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。